Skip to main content
logo
RedHill Biopharma Ltd. (RDHL)
NASDAQ: RDHL · Real-Time Price · USD
0.5468
+0.0078 (1.45%)
Oct 12, 2026, 1:13 PM EDT - Market open

RedHill Biopharma Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
3582913135
Market Cap Growth
-20.83%-34.04%-72.32%124.48%-90.53%-55.27%
Enterprise Value
-13124118188
Last Close Price
0.541.036.2136.50140.302580.00

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
---1.20--
PS Ratio
-18.34--0.211.58
PB Ratio
-1.23-1.7013.88-0.2615.23

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
-9.07--1.922.19

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
-1.000.25-0.080.57-2.539.89
Net Debt / Equity Ratio
3.79-0.680.91-2.12-2.125.61
Net Debt / EBITDA Ratio
0.520.370.670.58-2.96-0.79
Net Debt / FCF Ratio
0.530.400.480.26-3.49-0.76
Asset Turnover
-0.01--0.360.48
Inventory Turnover
----2.584.63
Quick Ratio
0.200.300.340.440.280.87
Current Ratio
0.340.340.540.810.441.09
Return on Equity (ROE)
------859.70%
Return on Assets (ROA)
-22.37%-22.79%-19.70%-6.56%-15.75%-28.06%
Return on Capital Employed (ROCE)
-1120.90%-129.10%154.90%-311.60%111.00%-81.40%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-73.16%-8.18%-103.97%83.26%-560.09%-72.30%
FCF Yield
-237.34%-137.19%-112.47%-58.60%-229.63%-48.20%
Buyback Yield / Dilution
--156.37%-375.56%-320.45%-32.46%-27.72%
SEC Filings: 10-K · 10-Q